Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Novel small conductance channel blockers presented by Acesion Pharma

Sep. 14, 2017

EMA grants orphan drug designation to Vivus' tacrolimus for PAH

Sep. 7, 2017

FDA approves new formulation of Tracleer for pediatric PAH

Sep. 7, 2017

Phase III results presented for anacetrapib in patients with atherosclerotic vascular disease

Sep. 7, 2017

Increased SIRT4 expression linked to accelerated heart failure development

Sep. 5, 2017

High mobility group protein B1 inhibitors disclosed by Kyungpook National University

Sep. 4, 2017

FDA issues refusal to file letter for SteadyMed's Trevyent NDA

Sep. 1, 2017

University of California, Oakland divulges new vectors encoding LAMP-2 isoforms

Aug. 31, 2017

AP-14145 shows selective SK channel targeting

Aug. 31, 2017

Treating angina with ivabradine/metoprolol FDC shows promise

Aug. 31, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...